| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.08. | KDA Group Inc: KDA Group appoints Potvin director | 2 | Stockwatch | ||
| 26.08. | Kda Group Appoints Louise Potvin To Its Board Of Directors | 1 | CNW | ||
| 02.06. | KDA Group Inc: KDA Group 250,000 shares for debt | 1 | Stockwatch | ||
| 30.05. | KDA Group Inc: KDA Group issues 250,000 shares for debt of $25,000 | 1 | Stockwatch | ||
| 30.05. | Kda Group Completes Debt Settlement | 1 | CNW | ||
| 05.05. | Kda Group Announces Results Of Shareholders' Annual General Meeting And The Settlement Of Judicial Claims | 1 | CNW | ||
| 10.04. | KDA Group Inc: KDA appoints Kirouac as chief technology officer of GTK | 1 | Stockwatch | ||
| 09.04. | Kda Group Announces The Appointment Of Martin Kirouac As Chief Technology Officer Of Its Subsidiary Groupe Technologique Kda | 1 | CNW | ||
| KDA GROUP Aktie jetzt für 0€ handeln | |||||
| 25.03. | KDA Group Inc: KDA Group closes acquisition of GTK interest | 4 | Stockwatch | ||
| 24.03. | Kda Group Announces The Acquisition Of The Minority Interest In Its Subsidiary Groupe Technologique Kda Inc. | 1 | CNW |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 38,850 | -0,79 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,080 | +1,52 % | Aktien KW 38 Warsh konnte nicht bremsen. Iran verhindert mehr. TACO gefragt! News. Rheinmetall. Mutares. Verbio. Lufthansa. Hapag Lloyd. Carl Zeiss MediTec. Verbio. BASF. DEFAMA. Vonovia. Aroundtown. SFC Energy. Dürr. Evonik. Continental. Elmos Semiconduc | Aktien - es gab eine Leitzinserhöhung in den USA. Da von allen erwartet konnten die Aktienmärkte damit relativ gut umgehen. Selbst Gold und Silber atmeten einmal kurz ein udn setzten danach zum neuen... ► Artikel lesen | |
| UNITEDHEALTH | 329,20 | +0,30 % | Dividendenbekanntmachungen (14.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) BROOKFIELD CORPORATION CA11271J1075 0,07 USD 0,0603 EUR BROOKFIELD WEALTH SOLUTIONS LTD BMG174341047 0,07 USD 0,0603 EUR CALAMOS... ► Artikel lesen | |
| HIMS & HERS HEALTH | 25,600 | +5,00 % | HIMS Bulls Should Heed This Historic Chart Signal | ||
| BICO GROUP | 1,976 | +0,41 % | BICO Group AB: Publication of BICO Group AB: Interim Report Q2 2026 | Improved profitability and AI advancements
"In the quarter we had a continued solid momentum with growth in our bench top instruments and consumables businesses, while still experiencing challenges... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| UNIDOC HEALTH | 0,050 | -7,04 % | UniDoc Health Corp.: UniDoc Health Equips San Juan, Puerto Rico Ambulances With Live Patient Video | Upgraded E-PTZ Camera Integrates into UniDoc Connect for Full In-Transit Patient Coverage Across San Juan's Ambulance Fleet TORONTO, ON / ACCESS Newswire / September 17, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)... ► Artikel lesen | |
| VERU | 2,445 | +2,09 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| VIROMED MEDICAL | 5,650 | -1,77 % | EQS-DD: Viromed Medical AG: Heike Perbandt, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
14.09.2026 / 18:05... ► Artikel lesen | |
| CLARIANE | 3,960 | +4,10 % | Clariane: Signing of a new €700 million syndicated revolving credit facility maturing 2031 | 21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026: following the success of its €500 million senior bonds offering completed on 8 September... ► Artikel lesen | |
| BONESUPPORT | 19,210 | +2,78 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q2 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2026.
"Strong growth and improved operating... ► Artikel lesen | |
| SENSEONICS | 8,200 | -1,80 % | Senseonics sees activist investor take a major stake | ||
| BEYOND AIR | 3,160 | 0,00 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| M3 INC | 9,978 | +1,18 % | Oasis Management Raises M3 Stake to 7.40% and Proposes Delisting | ||
| NANALYSIS SCIENTIFIC | 0,084 | -0,24 % | Nanalysis Scientific Corp.: Nanalysis Announces Second Quarter 2026 Results | Reports $9.7 Million in Quarterly Revenue and $0.9 Million in Adjusted EBITDA
CALGARY, AB, Aug. 24, 2026 /PRNewswire/ -- Nanalysis Scientific Corp. ("the Company"... ► Artikel lesen |